| Bliss GVS Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506197 |
NSE Symbol : BLISSGVS |
P/E(TTM) : 52.49 |
|
ISIN Demat : INE416D01022 |
Div & Yield% : 0.31 |
EPS(TTM) : 9.27 |
|
Book Value(₹) : 108.92 |
Market Cap(₹Cr) : 5,160.70 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 211.54 | 164.68 | 190.23 | 163.36 | 156.00 | 179.59 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 211.54 | 164.68 | 190.23 | 163.36 | 156.00 | 179.59 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 9.66 | 10.23 | 13.59 | 10.59 | 9.36 | 11.66 |
| Total Income | 221.20 | 174.91 | 203.82 | 173.96 | 165.36 | 191.25 |
| Total Expenditure | 167.39 | 140.34 | 159.96 | 130.60 | 142.27 | 153.86 |
| PBIDT | 53.81 | 34.57 | 43.86 | 43.36 | 23.09 | 37.40 |
| Interest | 1.81 | 1.48 | 2.71 | 5.11 | 1.30 | 0.67 |
| PBDT | 52.00 | 33.09 | 41.15 | 38.25 | 21.79 | 36.73 |
| Depreciation | 7.84 | 7.80 | 7.69 | 7.68 | 7.43 | 6.96 |
| Tax | 11.06 | 7.52 | 11.41 | 12.55 | 3.95 | 10.27 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.68 | -0.84 | -2.75 | -3.04 | -1.04 | -1.55 |
| Reported Profit After Tax | 32.42 | 18.61 | 24.79 | 21.05 | 11.45 | 21.05 |
| Extra-ordinary Items | 0.26 | -1.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 32.16 | 20.38 | 24.79 | 21.05 | 11.45 | 21.05 |
| EPS (Unit Curr.) | 3.06 | 1.76 | 2.35 | 2.00 | 1.08 | 2.00 |
| EPS (Adj) (Unit Curr.) | 3.06 | 1.76 | 2.35 | 2.00 | 1.08 | 2.00 |
| Calculated EPS (Unit Curr.) | 3.06 | 1.76 | 2.35 | 2.00 | 1.09 | 2.00 |
| Calculated EPS (Adj) (Unit Curr.) | 3.06 | 1.76 | 2.35 | 2.00 | 1.09 | 2.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 12.26 | 7.04 | 9.39 | 7.98 | 4.35 | 7.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 12.26 | 7.04 | 9.39 | 7.98 | 4.35 | 7.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 50.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.58 | 10.58 | 10.56 | 10.55 | 10.54 | 10.54 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.44 | 20.99 | 23.06 | 26.54 | 14.80 | 20.83 |
| PBDTM(%) | 24.58 | 20.09 | 21.63 | 23.41 | 13.97 | 20.45 |
| PATM(%) | 15.33 | 11.30 | 13.03 | 12.89 | 7.34 | 11.72 |
